BDBM72474 2-[1-(2-ethoxybenzyl)-4-[(1-methyl-3-phenyl-pyrazol-4-yl)methyl]piperazin-2-yl]ethanol::2-[1-[(2-ethoxyphenyl)methyl]-4-[(1-methyl-3-phenyl-4-pyrazolyl)methyl]-2-piperazinyl]ethanol::2-[1-[(2-ethoxyphenyl)methyl]-4-[(1-methyl-3-phenyl-pyrazol-4-yl)methyl]piperazin-2-yl]ethanol::2-[1-[(2-ethoxyphenyl)methyl]-4-[(1-methyl-3-phenylpyrazol-4-yl)methyl]piperazin-2-yl]ethanol::2-{1-(2-ethoxybenzyl)-4-[(1-methyl-3-phenyl-1H-pyrazol-4-yl)methyl]piperazin-2-yl}ethanol::MLS000732521::SMR000315532::cid_16189943
SMILES CCOc1ccccc1CN1CCN(Cc2cn(C)nc2-c2ccccc2)CC1CCO
InChI Key InChIKey=GVXIPHFHZWKCAH-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 72474
TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shanghai Qilu Pharmaceutical Research and Development Centre
US Patent
Shanghai Qilu Pharmaceutical Research and Development Centre
US Patent
Affinity DataIC50: 4.62nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
